Literature DB >> 11720843

Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat.

G Cavaletti1, G Tredici, M G Petruccioli, E Dondè, P Tredici, P Marmiroli, C Minoia, A Ronchi, M Bayssas, G G Etienne.   

Abstract

The aim of this study was to determine the influence of oxaliplatin scheduling on the onset of peripheral neurotoxicity and ototoxicity in a rat model. Animals were treated with four different schedules of oxaliplatin using two cumulative doses (36 and 48 mg/kg intraperitoneally (i.p.)). The neuropathological examination evidenced dorsal root ganglia (DRG) nucleolar, nuclear and somatic size reduction with nucleolar segregation in the treated rats. Sensory nerve conduction velocity (SNCV) was reduced after oxaliplatin treatment, while the auditory pathway was unaffected. After treatment, platinum was detected in the kidney, DRG and sciatic nerve. After a 5-week follow-up period, recovery of the pathological changes in the DRG and sciatic nerves occurred, although platinum was still detectable in these tissues. The following conclusions may be drawn: the main targets of oxaliplatin neurotoxicity were the DRG; the shorter the interval between the injections, the higher the severity of peripheral neuropathy and this was also related to the cumulative oxaliplatin dose; the peripheral neurotoxicity tended to be reversible; ototoxicity was absent even with high cumulative doses of oxaliplatin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720843     DOI: 10.1016/s0959-8049(01)00300-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  71 in total

1.  Discrepancy between the NCI-CTCAE and DEB-NTC scales in the evaluation of oxaliplatin-related neurotoxicity in patients with metastatic colorectal cancer.

Authors:  Naohiko Inoue; Hideyuki Ishida; Motohiko Sano; Tohru Kishino; Norimichi Okada; Kensuke Kumamoto; Keiichiro Ishibashi
Journal:  Int J Clin Oncol       Date:  2011-08-11       Impact factor: 3.402

2.  The effect of curcumin on oxaliplatin and cisplatin neurotoxicity in rats: some behavioral, biochemical, and histopathological studies.

Authors:  Mansour S Al Moundhri; Suhail Al-Salam; Ahmed Al Mahrouqee; S Beegam; Badreldin H Ali
Journal:  J Med Toxicol       Date:  2013-03

3.  N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data.

Authors:  Peng-Chan Lin; Ming-Yang Lee; Wei-Shu Wang; Chueh-Chuan Yen; Ta-Chung Chao; Liang-Tsai Hsiao; Muh-Hwa Yang; Po-Min Chen; Kon-Ping Lin; Tzeon-Jye Chiou
Journal:  Support Care Cancer       Date:  2006-02-01       Impact factor: 3.603

Review 4.  Toxic Peripheral Neuropathies: Agents and Mechanisms.

Authors:  William M Valentine
Journal:  Toxicol Pathol       Date:  2019-06-10       Impact factor: 1.902

5.  Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.

Authors:  W H Xiao; H Zheng; G J Bennett
Journal:  Neuroscience       Date:  2011-12-20       Impact factor: 3.590

6.  Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y.

Authors:  Elisabetta Donzelli; Maria Carfì; Mariarosaria Miloso; Alberto Strada; Stefania Galbiati; Martine Bayssas; Genevieve Griffon-Etienne; Guido Cavaletti; Maria Grazia Petruccioli; Giovanni Tredici
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

7.  Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice.

Authors:  Lauren E Ta; Allan J Bieber; Susan M Carlton; Charles L Loprinzi; Philip A Low; Anthony J Windebank
Journal:  Mol Pain       Date:  2010-03-05       Impact factor: 3.395

8.  Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue.

Authors:  Virginia Ip; Johnson J Liu; Julian F B Mercer; Mark J McKeage
Journal:  Mol Pain       Date:  2010-09-13       Impact factor: 3.395

9.  Oxaliplatin neurotoxicity--no general ion channel surface-charge effect.

Authors:  Amir Broomand; Elin Jerremalm; Jeffrey Yachnin; Hans Ehrsson; Fredrik Elinder
Journal:  J Negat Results Biomed       Date:  2009-01-12

10.  Oxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissue.

Authors:  Stephen M F Jamieson; Joshuan Subramaniam; Johnson J Liu; Nancy N Jong; Virginia Ip; Bronwen Connor; Mark J McKeage
Journal:  Mol Pain       Date:  2009-11-18       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.